BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21184759)

  • 1. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
    Albon S; Bunn C; Swana G; Karim Y
    J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzyme immunoassay for the detection of autoantibodies to nRNP and Sm: a rapid and sensitive alternative to current procedures].
    Blazek M; Naser W; Bayer-Beck J; Lakomek HJ; Werle E; Fiehn W
    Z Rheumatol; 1992; 51(2):87-93. PubMed ID: 1615735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to extractable nuclear antigen polypeptides: detection and its clinical significance].
    Xu YH
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):541-3, 573. PubMed ID: 1338517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
    Hauke G; Lührmann R; Metz B; Peter HH
    Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
    Sánchez Ibarrola A; Valdivieso R; Wong E; Sánchez Arroyo R
    Allergol Immunopathol (Madr); 1987; 15(4):195-200. PubMed ID: 3500626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of anti-Sm antibody analysis].
    Tojo T; Ogasawara T
    Nihon Rinsho; 1990 Feb; 48 Suppl():497-500. PubMed ID: 2113132
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection and differentiation of autoantibodies to extractable nuclear antigens with immunoenzyme tests].
    Horeschi G; Morenz J; Struy H
    Allerg Immunol (Leipz); 1987; 33(4):203-13. PubMed ID: 2449813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 11. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
    Warlow R; Carrano J; Dawkins R
    Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of Sm antibodies and clinical symptoms in systemic lupus erythematosus].
    Serfling U; Brenke A; Ziegler H; Barthelmes H; Sönnichsen N
    Dermatol Monatsschr; 1988; 174(11):667-70. PubMed ID: 3264793
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of the anti-Sm antibody].
    Chen DL
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):13-5. PubMed ID: 3109698
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis.
    Bunn CC; Gharavi AE; Hughes GR
    J Clin Lab Immunol; 1982 May; 8(1):13-7. PubMed ID: 6980286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
    Kameda H; Kuwana M; Hama N; Kaburaki J; Homma M
    J Rheumatol; 1997 Feb; 24(2):400-3. PubMed ID: 9035005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus.
    Sabbatini A; Dolcher MP; Marchini B; Bombardieri S; Migliorini P
    J Rheumatol; 1993 Oct; 20(10):1679-83. PubMed ID: 7507527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arthritis in definitive systemic lupus erythematosus].
    Haberhauer G
    Z Arztl Fortbild (Jena); 1990; 84(3):85-7. PubMed ID: 2343605
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
    Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
    J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.